APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 25 filers reported holding APTEVO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,124 | -77.7% | 142,800 | -1.2% | 0.00% | -100.0% |
| Q2 2023 | $211,116 | -27.9% | 144,600 | +0.6% | 0.00% | -33.3% |
| Q1 2023 | $292,633 | -11.2% | 143,800 | +1.2% | 0.00% | 0.0% |
| Q4 2022 | $329,672 | -26.2% | 142,100 | -3.3% | 0.00% | -25.0% |
| Q3 2022 | $447,000 | -14.7% | 146,900 | +0.4% | 0.00% | -20.0% |
| Q2 2022 | $524,000 | -39.7% | 146,300 | -1.1% | 0.01% | -37.5% |
| Q1 2022 | $869,000 | -29.5% | 148,000 | -5.6% | 0.01% | -27.3% |
| Q4 2021 | $1,233,000 | +316.6% | 156,700 | +1515.5% | 0.01% | +175.0% |
| Q1 2021 | $296,000 | -27.3% | 9,700 | -12.6% | 0.00% | -20.0% |
| Q4 2020 | $407,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |